DIFFERENTIAL ACTIVATION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS BY EICOSANOIDS

被引:622
作者
YU, K
BAYONA, W
KALLEN, CB
HARDING, HP
RAVERA, CP
MCMAHON, G
BROWN, M
LAZAR, MA
机构
[1] UNIV PENN, SCH MED,DEPT MED,DIV ENDOCRINOL DIABET & METAB, PHILADELPHIA, PA 19104 USA
[2] UNIV PENN, SCH MED,DEPT GENET, PHILADELPHIA, PA 19104 USA
[3] SANDOZ PHARMACEUT CORP, SANDOZ RES INST,PRECLIN RES,ONCOL RES PROGRAM, E HANOVER, NJ 07936 USA
[4] DANA FARBER CANC INST, DIV NEOPLAST DIS MECHANISMS, BOSTON, MA 02115 USA
关键词
D O I
10.1074/jbc.270.41.23975
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that regulate gene transcription in response to peroxisome proliferators and fatty acids. PPARs also play an important role in the regulation of adipocyte differentiation. It is unclear, however, what naturally occurring compounds activate each of the PPAR subtypes. To address this issue, a screening assay was established using heterologous fusions of the bacterial tetracycline repressor to several members of the peroxisome proliferator-activated receptor (PPAR) family. This assay was employed to compare the activation of PPAR family members by known PPAR activators including peroxisome proliferators and fatty acids. Interestingly, the activation of PPARs by fatty acids was partially inhibited by the cyclooxygenase inhibitor indomethacin, which prevents prostaglandin synthesis. Indeed, prostaglandins PGA1 and 2, PGD1 and 2, and PGJ2-activated PPARs, while a number of other prostaglandins had no effect. We also screened a variety of hydroxyeicosatetraenoic acids (HETEs) for the ability to activate PPARs. 8(S)-HETE, but not other (S)-HETEs, was a strong activator of PPAR alpha. Remarkably, PPAR activation by 8(S)-HETE was stereoselective. In addition, 8(S)-HETE was able to induce differentiation of 3T3-L1 preadipocytes. These results indicate that PPARs are differentially activated by naturally occurring eicosanoids and related molecules.
引用
收藏
页码:23975 / 23983
页数:9
相关论文
共 57 条
  • [1] ALLAN GF, 1992, J BIOL CHEM, V267, P19513
  • [2] CLONING OF A PROTEIN THAT MEDIATES TRANSCRIPTIONAL EFFECTS OF FATTY-ACIDS IN PREADIPOCYTES - HOMOLOGY TO PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS
    AMRI, EZ
    BONINO, F
    AILHAUD, G
    ABUMRAD, NA
    GRIMALDI, PA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (05) : 2367 - 2371
  • [3] A RETINOIC ACID RECEPTOR-ALPHA ANTAGONIST SELECTIVELY COUNTERACTS RETINOIC ACID EFFECTS
    APFEL, C
    BAUER, F
    CRETTAZ, M
    FORNI, L
    KAMBER, M
    KAUFMANN, F
    LEMOTTE, P
    PIRSON, W
    KLAUS, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (15) : 7129 - 7133
  • [4] Ausubel FM, 2003, CURRENT PROTOCOLS MO
  • [5] PPAR-RXR HETERODIMER ACTIVATES A PEROXISOME PROLIFERATOR RESPONSE ELEMENT UPSTREAM OF THE BIFUNCTIONAL ENZYME GENE
    BARDOT, O
    ALDRIDGE, TC
    LATRUFFE, N
    GREEN, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 192 (01) : 37 - 45
  • [6] ADIPOCYTE CONVERSION OF CULTURED 3T3-L1 PREADIPOCYTES BY BEZAFIBRATE
    BRANDES, R
    HERTZ, R
    ARAD, R
    NAISHTAT, S
    WEIL, S
    BARTANA, J
    [J]. LIFE SCIENCES, 1987, 40 (10) : 935 - 941
  • [7] BREGMAN MD, 1986, PROSTAGLANDINS, V26, P449
  • [8] PEROXISOME PROLIFERATOR AND RETINOID SIGNALING PATHWAYS COREGULATE PREADIPOCYTE PHENOTYPE AND SURVIVAL
    CHAWLA, A
    LAZAR, MA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (05) : 1786 - 1790
  • [9] PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)-GAMMA - ADIPOSE-PREDOMINANT EXPRESSION AND INDUCTION EARLY IN ADIPOCYTE DIFFERENTIATION
    CHAWLA, A
    SCHWARZ, EJ
    DIMACULANGAN, DD
    LAZAR, MA
    [J]. ENDOCRINOLOGY, 1994, 135 (02) : 798 - 800
  • [10] IDENTIFICATION OF 2 MESSENGER PPAR RELATED RECEPTORS AND EVIDENCE FOR THE EXISTENCE OF 5 SUBFAMILY MEMBERS
    CHEN, F
    LAW, SW
    OMALLEY, BW
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 196 (02) : 671 - 677